Ariad Sues Amgen, Wyeth Over Enbrel
Expanding an already contentious biotechnology dispute, drug maker Ariad Pharmaceuticals Inc. has filed a new patent infringement lawsuit against rivals Amgen Inc. and Wyeth over Amgen's popular anti-arthritis drugs, Enbrel and...To view the full article, register now.
Already a subscriber? Click here to view full article